Diabetic ketoacidosis: An overlooked child killer in sub-Saharan Africa?

Tropical Medicine and International Health

Volumn 18, Issue 11, 2013, Pages 1357-1364

  Murunga, A N ^a   Owira, P M O ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Africa; Children; Diabetes; Insulin; Ketoacidosis

Indexed keywords

ALBENDAZOLE; BICARBONATE; CALCIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; CATECHOLAMINE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ELECTROLYTE; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; PRAZIQUANTEL;

CHILD HEALTH; DIABETES; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE TREATMENT; HEALTH CARE; HEALTH POLICY; HEALTH RISK; IMMUNIZATION; SYMPTOM;

ABDOMINAL PAIN; ACUTE PANCREATITIS; AFRICA SOUTH OF THE SAHARA; BICARBONATE BLOOD LEVEL; BLOOD GLUCOSE MONITORING; BLOOD PH; BRAIN EDEMA; CARBON DIOXIDE TENSION; CAUSE OF DEATH; CHILDHOOD MORTALITY; COMORBIDITY; CONVULSION; CYTOKINE PRODUCTION; DEHYDRATION; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DIAGNOSTIC ERROR; DIARRHEA; ELECTROLYTE DISTURBANCE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE NEED; HEART ARRHYTHMIA; HEMOPTYSIS; HOOKWORM INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERKALEMIA; HYPERPNEA; HYPERVENTILATION; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; HYPOINSULINEMIA; HYPOKALEMIA; HYPOTENSION; HYPOXEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; INTRACRANIAL HYPERTENSION; KETOGENESIS; KETONURIA; LUNG INFILTRATE; MALARIA; MALARIA FALCIPARUM; MALNUTRITION; METABOLIC ACIDOSIS; MUCOSAL DRYNESS; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGICAL COMPLICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; OLIGURIA; OSMOTIC DIURESIS; PANCREAS ISLET BETA CELL; PENICILLIN RESISTANCE; POLYDIPSIA; POLYURIA; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; PROTEIN DEGRADATION; REVIEW; SCHISTOSOMIASIS; SUBSTITUTION THERAPY; TRADITIONAL HEALER; TUBERCULOSIS; VOMITING;

SUB-SAHARAN AFRICA;

AFRICA; CHILDREN; DIABETES; INSULIN; KETOACIDOSIS;

AFRICA SOUTH OF THE SAHARA; BRAIN EDEMA; CHILD; DEHYDRATION; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; HUMANS;

EID: 84886290616     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12195     Document Type: Review

References (67)

1. Alemu S, Dessie A, Seid E et al. (2009) Insulin-requiring diabetes in rural Ethiopia: should we re-open the case of malnutrition-related diabetes. Diabetologia 52, 1842-1845.
2. Alisjahbana B, Sahiratmadja E, Nelwan EJ et al. (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious Diseases 45, 428-435.
3. American Diabetes Association (2001) Position statement: hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 24, S83-S90.
4. American Thoracic Society, CDC, Infectious Diseases Society of America (2003) Treatment of Tuberculosis. MMWR Recomm Rep 52, 1-77.
5. Argent AC (2004) What determined the outcome of children with diabetic ketoacidosis admitted to the paediatric intensive care unit of a developing country. Pediatric Critical Care Medicine 5, 492-493.
6. Banerjee S, McCutchan JA, Ances BM et al. (2011) Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS 25, F1-F6.
7. Bui TP, Weather GA & Cameron EJ (2002) Trends in diabetic ketoacidosis in childhood and adolescents; 15-yr experience. Pediatric Diabetes 3, 82-88.
8. Burgen GA, Etteldorf JN, Fisher JN, et al. (1980) Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 3, 15-20.
9. Calderón-Salinas JV, Muñoz-Reyes EG, Guerrero-Romero JF et al. (2011) Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Molecular and cellular biochemistry. 357, 171-179.
10. Calvet HM & Yoshikawa TT (2001) Infections in diabetes. Infectious Diseases Clinics of North America 15, 407-421.
11. Carl CF, Hoffman WH & Passmore GG (2003) Diabetic ketoacidosis promotes a thrombotic state. Endocrine Research 29, 73-82.
12. Chase HP, Garg SK & Jelly DH (1990) Diabetic ketoacidosis in children and the role of outpatient management. Pediatrics in Review 11, 297-304.
13. Chutipongtanate S & Thongboonkerd V (2011) Ceftriaxone crystallization and its potential role in kidney stone formation. Biochemical and Biophysical Research Communications 406, 396-402.
14. Clark JA, Burny I, Sarnaik AP et al. (2006) Acute thiamine deficiency in diabetic ketoacidosis; diagnosis and management. Pediatric Critical Care Medicine 7, 595-599.
15. Danquah I, Bedu-Addo G & Mockenhaupt FP (2010) Type 2 diabetes mellitus and increased risk for malaria infection. Emerging Infectious Diseases 16, 1601-1604.
16. Delamaire M, Maugendre D, Moreno M et al. (1997) Impaired leucocyte functions in diabetic patients. Diabetic Medicine 14, 29-34.
17. Dragovic G & Jevtovic D (2012) The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients. Biomedicine & Pharmacotherapy 66, 308-311.
18. Edge JA, Ford-Adams ME & Dunger DB (1999) Causes of death in children with insulin dependent diabetes 1990-1996. Archives of Disease in Childhood 81, 318-323.
19. Edge JA, Hawkins MM, Winter DL et al. (2001) The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Archives of Disease in Childhood 85, 16-22.
20. Elamin A, Altahir H, Ismail B et al. (1992) Clinical pattern of childhood type 1 (insulin-dependent) diabetes in the Sudan. Diabetologia 35, 645-648.
21. Elamin A, Ghalib M, Eltayeb B et al. (1997) High incidence of type 1 diabetes mellitus in Sudanese children 1991-1995. Annals of Saudi medicine 17, 478-480.
22. Elmas N, Akinci A & Bilir P (2011) Tuberculous meningitis associated with diabetic ketoacidosis. Journal of Clinical Research in Pediatric Endocrinology 3, 222-224.
23. Faurholt-Jepsen D, Range N, Praygod G et al. (2011) Diabetes is a risk factor for pulmonary tuberculosis: a case controlled study from Mwanza, Tanzania. PloS One 6, e24215.
24. Faurholt-Jepsen D, Range N, PrayGod G et al. (2012) The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Tropical Medicine and International Health 17, 877-883.
25. Feeney ER & Mallon PW (2011) Insulin resistance in treated HIV infection. Best Practice & Research. Clinical Endocrinology & Metabolism 25, 443-458.
26. Foster DW & McGarry JD (1983) The metabolic derangements and treatment of diabetic ketoacidosis. New England Journal of Medicine 309, 159-169.
27. Gill GV, Tekle A, Reja A et al. (2011) Immunological and C-peptide studies of patients with diabetes in Northern Ethiopia: existence of an unusual subgroup possibly related to malnutrition. Diabetologia 54, 51-57.
28. Giordano B, Rosenbloom AL, Heller DR et al. (1977) Regional services for children and youth with diabetes. Pediatrics 60, 492-498.
29. Glaser N, Barnett P, McCaslin I et al. (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. New England Journal of Medicine 344, 264-269.
30. Haddad NG, Croffie JM & Rugster EA (2004) Pancreatic enzyme elevations in children with diabetic ketoacidosis. Journal of Pediatrics 145, 122-124.
31. von Herrath M (2009) A virus-gene collaboration. Nature 459, 518-519.
32. International Diabetes Federation (2011). Diabetes Atlas, 5th edn. International Diabetes Federation, Brussels, Belgium.
33. Jayashree M & Singhi S (2004) Diabetic ketoacidosis: predictors of outcome in paediatric intensive care unit of a developing country. Pediatric Critical Care Medicine 5, 427-433.
34. Joshi N, Caputo GM, Weitekamp MR & Karchmer AW (1999) Infections in patients with diabetes mellitus. New England Journal of Medicine 341, 1906-1912.
35. Kitabchi AE (1989) Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diabetes/Metabolism Reviews 5, 337-363.
36. Kitabchi AE, Umpirrez GE, Murphy MB & Kreisberg RA (2006) Hyperglycemic crises in adult patients with diabetes: a concensus statement from American Diabetes Association. Diabetes Care 29, 2739-2748.
37. Kitabchi AE, Umpirrez GE, Miles JM & Fischer JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32, 1335-1343.
38. Kroll MH, Bienzle U, Burger W & Weber B (1984) Chloroquine and pyrimethamine/sulfadoxine resistant malaria tropica in a child with diabetes mellitus. Monatsschrift für Kinderheilkunde 132, 301-302.
39. Lamni N, Karvonen M & Tuomolehto J (2005) Do microbes have a casual role in type 1 diabetes? Medical Science Monitor 1193, RA63-RA69.
40. Leung L, Wilson D & Manini AF (2011) Fatal toxicity from symptomatic hyperlactataemia: a retrospective cohort study of factors implicated with long-term nucleoside reverse transcriptase inhibitor use in a South African hospital. Drug Safety 34, 521-527.
41. Lévy-Marchal C, Patterson CC, Green A & on behalf of the EURODIAB ACE group (2001) Geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB study. Diabetologia 44, B75-B80.
42. Lin SF, Lin JD & Huang YY (2005) Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Medical Journal 28, 24-30.
43. Mbanya JC, Motala AA, Sobngwi E et al. (2010) Diabetes in sub-Saharan Africa. Lancet 375, 2254-2266.
44. McDonnell CM, Pedreira CC, Vadamayan B et al. (2005) Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high carbohydrate drinks worsening initial presentation? Pediatric Diabetes 6, 90-94.
45. McLarty DG, Kinabo L & Swai ABM (1990) Course and Prognosis. BMJ 300, 1107-1110.
46. Muller LM, Gorter KJ, Hak E et al. (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes. Clinical Infectious Diseases 41, 281-288.
47. Nacher M (2012) Helminth-infected patients with malaria: a low profile transmission hub? Malaria Journal 11, 376.
48. Nwosu BU, Stavre ZG, Maranda L et al. (2012) Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 25, 181-186.
49. Rabkin M & El-Sadr WM (2011) Why re-invent the wheel? Laveraging the lessons of HIV scale-up to confront non-communicable diseases. Global Public Health 6, 247-256.
50. Rabkin M, Melaku Z, Bruce K et al. (2012) Strengthening health systems for chronic care: laveraging HIV programs to support diabetes services in Ethiopia and Swaziland. Journal of Tropical Medicine. Article ID: 137460. doi:10.1155/2012/137460.
51. Restrepo BI, Fisher-Hoch SP, Crespo JG et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection 135, 483-491.
52. Rewers A (2012) Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children. Current Diabetes Reports 12, 524-532.
53. Rewers A, Klingensmith G, Davis C et al. (2008) Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 121, e1258-e1266.
54. Roivainen M & Klingel K (2009) Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52, 995-996.
55. Rosenbloom AL (2010a) Hyperglycemic hyperosmolar state: an emergency pediatric problem. Journal of Pediatrics 156, 180-184.
56. Rosenbloom AL (2010b) The management of diabetic ketoacidosis in children. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders 1, 103-120.
57. Rwitza HT, Swai ABM & McLary DG (1986) Failure to diagnose diabetic ketoacidosis in Tanzania. Diabetic Medicine 35, 645-648.
58. Sidibe EH (2000) Main complications of diabetes in Africa. Annales de médecine Interne 151, 624-628.
59. Sinha S & Sharma BS (2009) Neurocysticercosis: a review of current status and management. Journal of Clinical Neuroscience 16, 867-876.
60. Soler NG, Bennett MA, Fitzgerald MG et al. (1975) Electrocardiogram as guide to potassium replacement in diabetic ketoacidosis. Diabetes 23, 610-615.
61. Soliman AT, El-Nawawy AA, El-Azzouni OF et al. (1996) High prevalence of islet cell antibody and defective insulin release in children with schistosomiasis. Journal of Tropical Pediatrics 42, 46-49.
62. Spiegel A, Tall A, Raphenon G et al. (2003) Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 198-199.
63. Takasu N, Yamada T, Miura H et al. (1982) Rifampicin-induced early phase hyperglycemia in humans. The American Review of Respiratory Disease 125, 23-27.
64. Wang JY, Lee LN & Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease 9, 777-783.
65. Waterhouse M, Wilson C, White VL et al. (2005) Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis. Journal of the Royal Society of Medicine 98, 270-271.
66. Webb EA, Hesseling AC, Schaaf HS et al. (2009) High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes. The International Journal of Tuberculosis and Lung Disease 13, 868-874.
67. Wolfsdorf J, Craig ME, Daneman D et al. (2009) Diabetic ketoacidosis in children and adolescents with diabetes. Pediatric Diabetes 10, 118-133.